@cosimo1464 Profile picture

Lorenzo

@cosimo1464

at the end of the day you’re investing in people

Joined January 2022
Similar User
MNE photo

@MikeEdmunds1981

#keepitreal photo

@Riz_YNWA

aimisthegame12345 photo

@aimisthegame121

Brent Coppers photo

@bent_copers

Shaun photo

@shncoe

Matt photo

@MattBrian1988

11invest photo

@11invest

Waheed Rasab photo

@RasabWaheed

Eudaimonia Capital photo

@Aim_Eudaimonia

Conor munro photo

@Conormunro123

3bes photo

@garciastone

silverstoneaddict photo

@silverstonadict

Loosegoose photo

@BruceLoosegoose

GT photo

@grahamrtomo

MTrader photo

@trader24095618

🤞#avct

My expectation is that the potential value here is too great for #AVCT to relinquish to a LD or TO, so my feeling is that this moves more along the lines of a JV



Lorenzo Reposted

Genedrive’s CSO Gino Miele spoke to Elena Boland at TTP plc about the potential for CYP2C19 genotyping in acute care. Read the full story: ttp.com/insights/distr…



Lorenzo Reposted

Genedrive PLC: A 2024 Analysis and Future Outlook invst.ly/15nary



The dilution involved in a Nasdaq listing are multiples of AS’s last hurrah! Just don’t go there is my advice. And I’m with CC to remain independent and not sell the farm and draw the divi far into the golden future.



Lorenzo Reposted

The dilution involved in a Nasdaq listing are multiples of AS’s last hurrah! Just don’t go there is my advice. And I’m with CC to remain independent and not sell the farm and draw the divi far into the golden future.


Another welcome trial ~ these insurers no doubt see the potential and the more trials the more it reduces the odds of a hit! Good news - hope it moves the dial on the sp…but fear we need income to do that!


…not a regular occurrence!’

#AVCT - I think it interesting that the Co will provide ‘a business update after the AGM’ - this is a regular occurrence. I’m beginning to get the feeling that the company have a chart for getting out of the doldrums!



Lorenzo Reposted

Note, Novartis has an ‘exclusive worldwide rights to develop and commercialize therapeutic applications for a library of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74’. #AVCT

Tweet Image 1

#AVCT - could there be a practice whereby a ‘short’ is taken - thus ‘depressing’ the price and permitting another party to ‘load up’ at a cheaper market price?


Why precision-guided chemotherapy has driven a dealmaking boom ft.com/content/85ab8f… via @ft #avct - this is a great commentary on new but limited oncology … they still haven’t got their heads around Avacta’s great contribution to this space. I suppose it will out in the end!


Lorenzo Reposted

Last I will say on this but if we ALL #AVCT holders put a high sell-order on our stocks, I’m pretty sure this cannot be circumvented by inter-broker securities lending. For me as a Halifax SD customer, the cost is £2. PI’s should no longer be cannon fodder for II’s, HF’s etc.


#ondo #leakbot and met with sustained buying of the shares throughout the morning. Congratulations to @foster_ideas and the team

In case you missed it, more commentary on the successful deployment of LeakBot in Ohio with Fortune 100 insurer Nationwide #ONDO



#avct well wadya know good science being disseminated…more please.


#avct - I don’t have a lot of time on my hands generally - I have to work to enable to keep buying Avacta stock - but so incensed am I by the short taken by GSA Capital that I have written to them and asked them to cease with their parasitic practice. May I encourage others.


Oh get over yourself… ‘so so rude for blocking you’ what do you expect when your accusation is likely sans evidence of any description. There are many who do deep research into this stock and it’s all gratefully received by some of us who have a ‘day job’.

It's not like I don't try to help. I pointed out that @MylesMcNulty was pumping #AVCT, #BEN, #EISB, #TGR and was most likely being paid to do so. He just blocked me. So so rude! All these stocks are down heavily or have gone bust since.



However this maybe an object lesson in the difference between how CO’s fare on different market platforms in us and uk

$bcyc and #avct seemingly close competitors. It is a big market, however.



$bcyc and #avct seemingly close competitors. It is a big market, however.

Bicycle Therapeutics Set to Redefine Cancer Treatment Landscape with Trailblazing Therapies at 2024 AACR Annual Meeting: $BCYC Bicycle Therapeutics to Showcase Groundbreaking Therapies at 2024… dlvr.it/T3g9n6 #NASDAQ #customers #BCYC #MajorPharmaceuticalPreparations



#avct and @coughlin582 give insights into ADC vs PDC’s - the new Ford vs Ferrari where Ferrari powers ahead over time!

Our April newsletter is now live: consiliumsc.activehosted.com/index.php?acti… Featuring insights from Christina Coughlin, MD, PhD, Head of R&D at @avacta on the @AACR Annual Meeting and Dr Danuta Jeziorska, CEO and Co-Founder of Nucleome Therapeutics on World DNA Day. #ICRConsilium #Newsletter

Tweet Image 1


Loading...

Something went wrong.


Something went wrong.